Schedule Of Quarterly Financial Data - Schedule of Selected Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 7,347	$ 5,378
General and administrative	7,306	3,179
Total operating expenses	14,653	8,557
Loss from operations	(14,653)	(8,557)
Net loss	(14,653)	(8,557)
Net loss attributable to common stockholders	$ (14,653)	$ (10,340)
Net loss per share attributable to common stockholders – basic and diluted	$ (1.47)	$ (3.02)